A method for assessing drug therapy appropriateness☆

Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care

“…It was not within the objective of this study to evaluate the cost effectiveness. However, according to Hanlon et al [32], their research assistant required approximately 45 min to prepare each medical information abstract utilised by the raters, and the raters spent approximately 10 min evaluating the appropriateness of each medication. In our study, we estimated that GPs needed 1 h per patient, before and after the intervention, respectively, in order to collect and communicate patient details; however, feedback from several GPs indicated that more time was spent per patient.…”

“…A score of 0 was given for all criteria rated as appropriate or marginally appropriate. For more information on the MAI, other references should be consulted [31][32][33].…”

Appropriateness of antibiotic prescribing in veterans with community-acquired pneumonia, sinusitis, or acute exacerbations of chronic bronchitis: A cross-sectional study

“…The MAI is an instrument that has demonstrated good intra-and inter-rater reliability, face validity, and feasibility when applied to medications taken by patients. [8][9][10][11][12][13][14][15] The MAI measures ten domains of prescribing (i.e., indication, effectiveness, dosage, directions, practicality, drug-drug interactions, drugdisease interactions, unnecessary duplication, duration, and expensiveness) as illustrated in Appendix I. 10;11 For each criterion, the index has specific instructions, operational definitions, and examples.…”

Legal implications of deprescribing: a case scenario

“…Provided a patient is made aware of all material risks and reasonable alternatives then a prescriber is likely to satisfy the test for informed consent. While prescribers have access to a variety of tools to support safe deprescribing, [12][13][14][15][16] and alternative treatments are available for many conditions, the challenge is how we identify risks that are material to our patients. Patientcentred conversations 17 in the context of structured review 18 may support embedding this in our daily practice.…”